GOLDMAN SACHS GROUP INC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 109 filers reported holding NEVRO CORP in Q3 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$11,856,633
+224.9%
616,890
+329.7%
0.00%
+100.0%
Q2 2023$3,648,974
-44.5%
143,547
-21.0%
0.00%0.0%
Q1 2023$6,569,661
-46.9%
181,733
-41.8%
0.00%
-66.7%
Q4 2022$12,366,026
+192.1%
312,273
+243.7%
0.00%
+200.0%
Q3 2022$4,234,000
+12.9%
90,855
+6.2%
0.00%0.0%
Q2 2022$3,750,000
-45.0%
85,549
-9.2%
0.00%0.0%
Q1 2022$6,818,000
-9.3%
94,259
+1.6%
0.00%0.0%
Q4 2021$7,520,000
+88.8%
92,769
+171.1%
0.00%0.0%
Q3 2021$3,982,000
-78.8%
34,218
-69.8%
0.00%
-75.0%
Q2 2021$18,812,000
-61.2%
113,465
-67.3%
0.00%
-66.7%
Q1 2021$48,461,000
+2.7%
347,388
+27.4%
0.01%0.0%
Q4 2020$47,188,000
+9.6%
272,603
-11.8%
0.01%0.0%
Q3 2020$43,039,000
+16.2%
308,965
-0.3%
0.01%
+9.1%
Q2 2020$37,035,000
+97.5%
309,996
+65.3%
0.01%
+57.1%
Q1 2020$18,752,000
-39.0%
187,558
-28.2%
0.01%
-12.5%
Q4 2019$30,722,000
+50.3%
261,374
+10.0%
0.01%
+33.3%
Q3 2019$20,434,000
+370.9%
237,689
+255.1%
0.01%
+500.0%
Q2 2019$4,339,000
-47.9%
66,929
-49.8%
0.00%
-66.7%
Q1 2019$8,334,000
+186.4%
133,325
+78.2%
0.00%
+200.0%
Q4 2018$2,910,000
-42.1%
74,826
-15.1%
0.00%0.0%
Q3 2018$5,023,000
-91.6%
88,129
-88.2%
0.00%
-93.8%
Q2 2018$59,868,000
-24.4%
749,756
-18.0%
0.02%
-20.0%
Q1 2018$79,231,000
+19.0%
914,171
-5.2%
0.02%
+25.0%
Q4 2017$66,580,000
-39.2%
964,356
-19.9%
0.02%
-40.7%
Q3 2017$109,428,000
+27.9%
1,204,093
+4.8%
0.03%
+22.7%
Q2 2017$85,525,000
-38.6%
1,149,064
-22.7%
0.02%
-42.1%
Q1 2017$139,257,000
+35.7%
1,486,197
+5.2%
0.04%
+31.0%
Q4 2016$102,639,000
+23.4%
1,412,582
+77.2%
0.03%
+16.0%
Q3 2016$83,202,000
+535.2%
797,032
+348.8%
0.02%
+525.0%
Q2 2016$13,099,000
-63.1%
177,599
-71.9%
0.00%
-66.7%
Q1 2016$35,531,000
+149.4%
631,568
+199.2%
0.01%
+200.0%
Q4 2015$14,249,000
-5.4%
211,067
-35.0%
0.00%
-20.0%
Q3 2015$15,061,000
+236.5%
324,673
+289.9%
0.01%
+150.0%
Q2 2015$4,476,000
+1119.6%
83,270
+776.4%
0.00%
Q4 2014$367,0009,5010.00%
Other shareholders
NEVRO CORP shareholders Q3 2015
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders